Journal for ImmunoTherapy of Cancer (Nov 2021)
747 CodaLytic™, a novel codon-pair deoptimized influenza virus creates an immune-stimulatory tumor microenvironment leading to monotherapy efficacy in a preclinical model of breast cancer
Abstract
No abstracts available.